NCT02460497

Brief Summary

The purpose of this study is to characterize the effect of Minoxidil 2% Solution and Botanical Hair Solution Regimen in women with thinning hair and female pattern hair loss/androgenic alopecia (Ludwig I and II).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 27, 2015

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

May 29, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 2, 2015

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 19, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 19, 2015

Completed
7.9 years until next milestone

Results Posted

Study results publicly available

August 1, 2023

Completed
Last Updated

August 1, 2023

Status Verified

July 1, 2023

Enrollment Period

4 months

First QC Date

May 29, 2015

Results QC Date

March 20, 2023

Last Update Submit

July 14, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change From Baseline in Investigator's Rating of Global Photographs at Week 12

    The Investigator or a trained grader rated each participant's standardized global photographs for improvement from baseline for parameters like hair thinning, hair growth, impression of scalp hair coverage and overall perception of treatment benefit using a 1-to-7-point Likert scale. The score on the scale ranged from 1 (minimum) to 7 (maximum), that is, (1) Entirely Disagree; (2) Mostly Disagree; (3) Somewhat Disagree; (4) Neither Agree nor Disagree; (5) Somewhat Agree; (6) Mostly Agree; (7) Entirely Agree.

    At Week 12

Secondary Outcomes (4)

  • Change From Baseline in Participant Rating at Week 12

    At Week 12

  • Mean Change From Baseline in Shed Hair Count

    At Week 12

  • Number of Participants in Each Response Category Based on Subject Satisfaction Questionnaire

    At Week 4, 6 and 12

  • Number of Participants With Adverse Events (AEs)

    From start of study drug administration up to Week 12

Study Arms (1)

Treatment

EXPERIMENTAL
Drug: Treatment: Minoxidil 2% / Botanical Hair Solution for Women

Interventions

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Female patients age 18 to 60 years at the time of enrollment.
  • Women who have self-perceived thinning hair.
  • Women who have presentation of female pattern hair loss/androgenic alopecia (Ludwig I and II).

You may not qualify if:

  • History of allergic reactions or severe intolerance to minoxidil and Botanical Hair Solution product ingredients.
  • Plan to use any other concomitant therapy to treat hair loss, regrowth or volume during the study.
  • Subjects taking or planning to take topical or systemic prescription or OTC medications for treating hair loss and/or hair volume.
  • \. Any significant history of concurrent medical disease, which in the judgment of the Investigator, would make the subject inappropriate for entry to this study including history of skin disease that may confound study results.
  • \. Subjects who have recently (within the last 6 months) started the use of hormones for birth control or hormone replacement therapy (HRT). Women currently using hormones for birth control or HRT must have been on a stable dose (6 months or longer) in order to be eligible for the study.
  • \. Pregnant or breast-feeding females or women planning to become pregnant during the course of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stephens & Associates

Richardson, Texas, 75081, United States

Location

MeSH Terms

Conditions

Alopecia

Condition Hierarchy (Ancestors)

HypotrichosisHair DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Clinical Operations
Organization
Galderma

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 29, 2015

First Posted

June 2, 2015

Study Start

May 27, 2015

Primary Completion

September 19, 2015

Study Completion

September 19, 2015

Last Updated

August 1, 2023

Results First Posted

August 1, 2023

Record last verified: 2023-07

Locations